espite decades of research, and many promising hypotheses, the underlying etiology and pathophysiology of psychiatric illness remains unknown. There is evidence for the involvement of the HPA axis, monoamine neurotransmitters, inflammation, early life events, and the environment, among other factors, 1 but, to date, there has not been a unifying theory to connect these different lines of research. Concurrently, there has been burgeoning interest in the role the gut microbiota may play in health and disease. In fact, the gut microbiota influences many of the factors that may be involved in psychiatric illness and is shaped by early life events and environmental factors, including diet, migration, and urbanicity.
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espite decades of research, and many promising hypotheses, the underlying etiology and pathophysiology of psychiatric illness remains unknown. There is evidence for the involvement of the HPA axis, monoamine neurotransmitters, inflammation, early life events, and the environment, among other factors, 1 but, to date, there has not been a unifying theory to connect these different lines of research. Concurrently, there has been burgeoning interest in the role the gut microbiota may play in health and disease. In fact, the gut microbiota influences many of the factors that may be involved in psychiatric illness and is shaped by early life events and environmental factors, including diet, migration, and urbanicity. 2 There is now a wealth of animal studies demonstrating that the gut microbiota plays a critical role in modulating the brain and behaviour; however, to date, there has been a paucity of studies looking at the gut microbiota in psychiatric illness. Given the potential for development of preventative and therapeutic interventions targeting the microbiota, it is essential that clinical studies of the gut microbiota in psychiatric illness be performed.
The Gut-Brain Axis
Connections between the gut and the brain are evident in our common lexicon when we refer to gut feelings, or people having butterflies in their stomach, when they are anxious. The gut and the brain are intimately connected by several, bidirectional, signalling pathways, including neural, humoral, and immune mechanisms. 2, 3 From a neural perspective, the gut is under both intrinsic and extrinsic control. The intrinsic pathways comprise the enteric nervous system, the so-called second brain, consisting of between 200 and 600 million neurons located within the wall of the GI tract itself, which controls and coordinates GI functions essential for digestion, among others. The enteric nervous system is modulated by extrinsic innervation, which includes both vagal and sacral parasympathetic fibres and splanchnic sympathetic fibres. The vagus nerve is the primary connection between the brain and the proximal gut, while the sacral parasympathetics connect the distal third of the colon. The brain stem nuclei of the vagus communicate in a bidirectional fashion with higher brain centres, including the limbic system, and, as a result, are involved in fear, arousal, and emotional regulation, as well as sensory and motor functions. 3 Humoural connections include the HPA axis, which mediates the stress response, as well as enteroendocrine cells, which release neuropeptides and gut peptides that can act locally and on the brain through vagal and spinal afferents or through the circumventricular organs where the blood-brain barrier is more permeable. Immune cells in the gut can also activate vagal and spinal afferents and thereby signal to the brain, and can be modulated by descending inputs as well as hormonal factors, such as cortisol. The Microbiota-Gut-Brain Axis
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The body is home to over 100 trillion bacteria, most of which are located in the distal gut. That corresponds to 10 times the number of human cells in the body, 150 times the number of genes in the human genome, with more than 1000 species and more than 7000 strains. The microbiota differs between people and is generally considered to be relatively stable in adults, although changes may occur as a result of significant alterations in diet, travel, probiotic or antibiotic use, and disease. Both the balance and function of the microbiota is important for maintaining health, and its disruption contributes to various adverse health outcomes and disease, ranging from irritable bowel syndrome 2 to obesity. 4 The concept of the gut-brain axis has recently been supplanted by the microbiota-gut-brain axis, emphasizing the important role the gut microbiota plays in mediating brain responses. 2 The microbiota may communicate with the brain through several pathways ( Figure 1 ). Bacterial products secreted into the bloodstream may gain direct access to the brain through the circumventricular organs. Bacteria may also signal to the brain via immune pathways through the triggering of cytokine production by mucosal immune cells. The autonomic and enteric nervous systems, particularly the vagus nerve, also serve an important role in relaying bacterial signals to the central nervous system. Bacteria can also affect tryptophan metabolism and the production of 5-hydroxytryptamine, as well as kynurenine, which can both have important effects on the brain. 2, 5 Finally, bacteria themselves can produce neurotransmitters and neuroactive products, including gamma-aminobutyric acid, serotonin, dopamine, acetylcholine, and noradrenaline. 6 In true bidirectional fashion, the brain can influence the microbiota through the secretion of cortisol and sympathetic neurotransmission, changing gut motility, secretion, and mucin production, which can affect the habitat of the resident microbiota and thereby alter the composition of the microbiota. 2 Similarly, cortisol and other factors can affect immune function and bacterial gene expression and signaling, which can change the composition and activity of the microbiota. The Gut Microbiota, the Brain, and
Behaviour in Animal Models
It has been recognized for decades that stress plays an important role in psychiatric illnesses, including anxiety and depression. Various different types of stress, including maternal separation, chronic restraint stress, and social stress, have all been shown to change the composition of the gut microbiota. 7, 8 These changes are often paralleled by alterations in inflammatory markers and the HPA axis. The gut microbiota has also been shown to play an important role in the development of the HPA stress response. Sudo et al 9 found an exaggerated HPA stress response in germfree mice, compared with mice with a normal microbiota free of specific pathogens (specific pathogen-free mice), which was paralleled by reduced BDNF levels in the cortex and hippocampus. This exaggerated HPA response was reversed by administration of Bifidobacterium infantis or specific pathogen-free feces at 6 weeks of age, but not 8 or 14 weeks. 9 This suggests that the gut microbiota plays a critical role in programming the HPA stress response during a critical period in early life.
Germ-free mice offer a unique opportunity to investigate how the microbiota influences behaviour. Studies comparing germ-free mice to their specific pathogen-free counterparts have shown distinct changes in exploratory behaviour and the so-called anxiety phenotype in studies such as the elevated plus maze or light-dark testing. 10 Germfree mice also display cognitive deficits and impairment in social development, compared with specific pathogen-free mice. 11, 12 Several studies have demonstrated that manipulation of the gut microbiota can have a significant impact on animal behaviour. Studies from our group have shown that administration of antibiotics (neomycin, bacitracin, and pimaricin) to conventional mice increased exploratory behaviour in association with changes in the gut microbiota and an increase in hippocampal BDNF. 13 Subsequent studies have capitalized on different strains of mice having different behavioural phenotypes and microbiota profiles. BALB/c will mice tend to be more timid and anxious in experimental paradigms, while NIH Swiss mice are more adventurous. When normally timid, germ-free BALB/c mice are colonized with the microbiota of the more outgoing NIH Swiss mice, they exhibit more exploratory behaviour. Similarly, when the more adventurous NIH Swiss germfree mice are colonized with the microbiota of the timid BALB/c mice, they show reduced exploratory behaviour. 13 These changes in behaviour were accompanied by central changes in BDNF. 13 This study suggests that manipulation of the gut microbiota can have dramatic effects on the brain and behaviour, and there may be adoptive transfer of behavioural phenotypes with microbiota transplantation.
Similarly, administration of probiotics can have significant effects on behaviour in animal models. Administration of Lactobacillus rhamnosus, Lactobacillus helveticus R0052, Bifidobacterium longum R0175, and Bifidobacterium longum NCC3001 have all been demonstrated to reduce anxiety behaviour in animal models. 6 Bifidobacterium infantis has also been demonstrated to normalize depressive behaviour in a maternal separation model, 14 while Lactobacillus helveticus and Bifidobacterium longum reversed depressive behaviours in a post-myocardial infarction model in rats. Several of these studies investigated potential mechanisms by which these phenotypic changes occur, and it appears that some probiotics, such as Lactobacillus rhhamnosus or Bifidobacterium longum, may depend on vagal activation, while others mediate their effect through inflammatory pathways, changes in serotonin metabolism, and central changes in BDNF and noradrenaline. 6 
The Gut Microbiota and Psychiatric Illness
Despite the impressive body of animal work supporting the critical importance of the gut microbiota in behaviour and brain processes, there has been a distinct absence of work in clinical populations. To date, most work in human samples has been on healthy volunteers. These studies have shown that probiotics can reduce psychological distress 16 and alter brain activity in response to emotional stimuli in healthy people. 17 There has been interest in the gut microbiota in children with ASD, which has been driven in part by the observation that GI symptoms are prevalent in these patients. Several small studies have demonstrated alterations in the gut microbiota in patients with ASD. 2 A single, open study of oral vancomycin showed benefit in 8 out of 10 patients with late-onset observation, but, to date, this has not been replicated or subjected to investigation in a randomized controlled trial. 
A Call for Translation
There is a distinct paucity of studies of the gut microbiota in clinical samples of patients with psychiatric illness, other than ASD, despite the extensive animal work we have outlined. Patients are becoming increasingly aware of this field of research, and many are already using probiotics, yogurts, and fermented foods in an attempt to manipulate their own gut bacteria. Given the potential influence of the microbiota on the brain and behaviour, it is critical that rigorously conducted studies be performed in human populations with psychiatric illness to help guide preventative and treatment interventions. If prebiotics, probiotics, or antibiotics can influence the brain and change behaviour, this would represent one of the first substantive advances in therapeutics in psychiatry in decades. Fecal transplantation is being increasingly used in patients with Clostridium difficile infection and other GI diseases, and it may represent a potential therapeutic option in patients with treatment-resistant and severe illness. Unfortunately, these interventions will remain in the realm of lofty ideas until appropriate translational clinical studies are performed. The dramatic effects of manipulation of the gut microbiota in animal studies demand that these clinical studies be performed urgently to determine whether these ideas translate into human populations and might lead to meaningful therapeutic advances.
